| This article has been cited by |
| 1 | Lessons Learned from Two Decades of Anticancer Drugs | |
| Zhichao Liu,Brian Delavan,Ruth Roberts,Weida Tong |
| Trends in Pharmacological Sciences.2017;38(10)852 |
| [DOI] |
|
| 2 | [18F]FLT: An imaging biomarker of tumour proliferation for assessment of tumour response to treatment | |
| Dmitry Soloviev,David Lewis,Davina Honess,Eric Aboagye |
| European Journal of Cancer.2012;48(4)416 |
| [DOI] |
|
| 3 | Pharmacological and Cellular Significance of Triazole-Surrogated Compounds | |
| Naimish Kumar Verma,Dhananjoy Mondal,Smritilekha Bera |
| Current Organic Chemistry.2020;23(23)2305 |
| [DOI] |
|
| 4 | Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials | |
| Jean-Marie Michot,Lina Benajiba,Laura Faivre,Capucine Baldini,Lelia Haddag,Clement Bonnet,Christophe Massard,Frederic Bigot,Camille Bigenwald,Benjamin Verret,Zoé A. P. Thomas,Andrea Varga,Anas Gazzah,Antoine Hollebecque,David Ghez,Julien Lazarovici,Rastilav Balheda,Aurore Jeanson,Sophie Postel-Vinay,Alina Danu,Jean-Charles Soria,Xavier Paoletti,Vincent Ribrag |
| Investigational New Drugs.2018;36(1)62 |
| [DOI] |
|
| 5 | Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials | |
| Margaret S. Landis |
| Investigational New Drugs.2017;25(1)297 |
| [DOI] |
|
| 6 | Auricular Vagus Neuromodulation—A Systematic Review on Quality of Evidence and Clinical Effects | |
| Nishant Verma,Jonah D. Mudge,Maïsha Kasole,Rex C. Chen,Stephan L. Blanz,James K. Trevathan,Eric G. Lovett,Justin C. Williams,Kip A. Ludwig |
| Frontiers in Neuroscience.2021;15(1)297 |
| [DOI] |
|
| 7 | Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do? | |
| Zhe Li,Qin Li,Jun Wu,Manyuan Wang,Junxian Yu |
| Molecules.2016;21(10)1331 |
| [DOI] |
|
| 8 | Window of Opportunity Clinical Trials to Evaluate Novel Therapies for Brain Tumors | |
| Visish M. Srinivasan,Chibawanye Ene,Brittany Parker Kerrigan,Frederick F. Lang |
| Neurosurgery Clinics of North America.2021;32(1)93 |
| [DOI] |
|
| 9 | Window of Opportunity Clinical Trials to Evaluate Novel Therapies for Brain Tumors | |
| Luz Romero,José Miguel Vela |
| Neurosurgery Clinics of North America.2014;32(1)59 |
| [DOI] |
|
| 10 | Evaluation of two-stage designs of Phase 2 single-arm trials in glioblastoma: a systematic review | |
| Wonsuk Yoo,Seongho Kim,Michael Garcia,Shwetal Mehta,Nader Sanai |
| BMC Medical Research Methodology.2022;22(1)59 |
| [DOI] |
|
